SUMMIT SECURITIES GROUP LLC
Broker-DealerPosition in COGT — Cogent Biosciences, Inc.
CIK 1531593
NEW YORK, NY
Position in COGT
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$46,072
New position
Shares Held
1,197
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUMMIT SECURITIES GROUP LLC holds $1,851,878 across 25 Biotechnology names. COGT ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
23,000 | $1,212,560 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
138 | $106,624 | |
| 3 | MRNA |
Moderna, Inc.
|
1,626 | $82,600 | |
| 4 | CRMD |
CorMedix Inc.
|
10,256 | $69,638 | |
| 5 | FULC |
Fulcrum Therapeutics, Inc.
|
6,975 | $53,498 | |
| 6 | COGT |
Cogent Biosciences, Inc.
This page
|
1,197 | $46,072 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
460 | $42,494 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
400 | $38,900 |
All Filings in COGT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,072 | 1,197 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||